Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome
Source: View publication →
In patients with moderate-to-severe ARDS, an aggressive 'open lung' strategy involving lung recruitment maneuvers and PEEP titration resulted in higher 28-day all-cause mortality compared to a conventional low-PEEP strategy.
Key Findings
Study Design
Study Limitations
Clinical Significance
This trial fundamentally shifted clinical practice away from the routine, aggressive application of recruitment maneuvers and titrated high-PEEP strategies in ARDS, emphasizing that such interventions may do more harm than good in a general moderate-to-severe ARDS population.
Historical Context
The 'open lung approach' was historically theorized to improve oxygenation and prevent atelectrauma in ARDS by opening collapsed alveoli and maintaining them with higher PEEP. While smaller studies and systematic reviews previously suggested potential benefits, the ART trial was the definitive, large-scale investigation designed to test this hypothesis in clinical practice, ultimately contradicting the prevailing enthusiasm for routine recruitment maneuvers.
Guided Discussion
High-yield insights from every perspective
Physiologically, why might a 'recruitment maneuver' using high airway pressures (up to 60 cm H2O) lead to hemodynamic instability in an ARDS patient?
Key Response
High intrathoracic pressures generated during recruitment maneuvers increase pleural pressure, which decreases the pressure gradient for venous return (reducing preload) and increases right ventricular afterload. This can lead to a sudden drop in cardiac output and potentially cardiac arrest, especially in patients who are not fluid-responsive.
The ART trial showed higher mortality in the recruitment group. How should this finding influence your bedside decision to use recruitment maneuvers for a patient with refractory hypoxemia in the ICU?
Key Response
Recruitment maneuvers should not be used routinely in moderate-to-severe ARDS. While they may transiently improve oxygenation, the ART trial demonstrated a significant increase in 28-day mortality and pneumothorax. Clinicians should reserve recruitment only for salvage therapy in life-threatening hypoxemia, recognizing it as a high-risk intervention rather than standard care.
Considering the 'decremental PEEP' titration protocol used in the ART trial, how might the concept of lung stress and strain explain the increased mortality compared to the low-PEEP strategy?
Key Response
The ART protocol often resulted in very high PEEP levels based on static compliance. In many patients, this likely caused alveolar overdistension (increased strain) in the non-recruitable portions of the lung. This 'volutrauma' and 'barotrauma' from excessive PEEP potentially outweighed the benefits of preventing 'atelectrauma' in recruitable segments, shifting the balance toward iatrogenic injury.
The ART trial is often cited as a turning point in ARDS management. What does this study teach us about the reliability of physiological surrogates, such as the PaO2/FiO2 ratio, as markers for long-term clinical outcomes?
Key Response
The study is a classic example of a 'dissociation' between physiological improvement and survival. The experimental group showed improved oxygenation and compliance initially, yet had higher mortality. It serves as a teaching point that interventions improving gas exchange can still be lethal if the mechanical cost of that improvement (lung injury/hemodynamic stress) is too high.
Scholarly Review
Critical appraisal through the lens of expert reviewers and guideline development
The ART trial utilized a highly standardized, multi-step intervention (maneuver + titration). From a trial design perspective, how does the complexity of the 'experimental bundle' limit our ability to identify whether the harm was caused by the recruitment maneuver itself or the subsequent high PEEP levels?
Key Response
Because the intervention was a composite of a high-pressure maneuver (up to 60 cm H2O) and a titration strategy, the study cannot isolate the specific driver of mortality. This 'black box' effect of bundled interventions means we cannot definitively say if a gentler recruitment maneuver or a different titration target (e.g., driving pressure-based) would have yielded the same results.
A critical reviewer might argue that the ART trial was stopped early for harm, but the control group's PEEP levels were lower than those used in many previous 'high-PEEP' trials. Does this 'low-PEEP' control group represent a fair contemporary standard of care, or does it bias the results toward the intervention group's harm?
Key Response
If the control group received 'sub-optimal' low PEEP, the mortality gap might actually be underestimated. However, a reviewer would focus on the safety signal: the fact that three patients had cardiac arrest during maneuvers. This objective safety signal often outweighs concerns about the control group's specific PEEP settings when determining editorial significance and clinical safety.
How do the results of the ART trial reconcile with the 2017 ATS/ESICM/SCCM clinical practice guidelines, which initially gave a conditional recommendation for recruitment maneuvers?
Key Response
The 2017 guidelines were written as ART was being finalized. Post-ART, the consensus shifted significantly. While older meta-analyses suggested benefit, ART (as the largest trial) provides high-level evidence against routine recruitment maneuvers. Current guidelines (like the ESICM 2023 update) now recommend against the routine use of high-pressure recruitment maneuvers in patients with ARDS, effectively downgrading the previous conditional recommendation.
Clinical Landscape
Noteworthy Related Trials
ARDSNet ALVEOLI Trial
Tested
Higher PEEP strategy
Population
Patients with acute lung injury and ARDS
Comparator
Lower PEEP strategy
Endpoint
Hospital mortality
EXPRESS Trial
Tested
Mechanical ventilation with high PEEP set to achieve plateau pressure 28-30 cm H2O
Population
Patients with moderate to severe ARDS
Comparator
Minimal PEEP to keep FiO2 low
Endpoint
Day-28 mortality
LOVS Trial
Tested
High PEEP and recruitment maneuver strategy
Population
Patients with acute lung injury or ARDS
Comparator
Conventional low PEEP strategy
Endpoint
Death at 28 days
Tailored to your role
Want this tailored to you?
Add your specialty or training stage to get role-specific takeaways and more questions.
Personalize this analysis